Here are the Achievement of ABC Goals in Type 2 Diabetes in Real-life journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
Junior achievement of western pa, achievement of abc goals in type 2 diabetes in adults, achievement of abc goals for diabetes, junior achievement of greater washington, achievement of abc goals in type 2 diabetes in adolescents, achievement of abc goals in type 2 diabetes in children, achievement of abc goals in type 2 diabetes injections.
Achievement of ABC Goals in Type 2 Diabetes in Real-life
Introduction: This real-life observational study from a diabetes centre in Western India reports the status of A1C (glycated hemoglobin), blood pressure, and cholesterol levels (ABC goals) currently achieved in type 2 diabetic patients. Research design and
methods: A cohort of 497 patients of type 2 diabetes first seen at the Diabetes Endocrine Nutrition Management and Research Centre from the years 2014 to 2017 were followed for a median [interquartile range (IQR)] duration of 21.5 (7, 33) months. A minimum of two follow-up clinical evaluations and investigations were analyzed.
Results: Hemoglobin A1C (HbA1c) dropped significantly in the whole cohort (HbA1c, Percent: initial 9.0 ± 1.98, follow-up 7.66 ± 1.73; p < 0.0001). Increasing duration of diabetes showed a significantly poorer achievement of HbA1c targets on follow-up (HbA1c 0–5 years vs 5.1–10 years and >10 years, p < 0.001). Pretreatment HbA1c of <6, 6.1–7, 7.1� ��7.5, 7.6–8, 8.1–9, and >9% was seen in 2, 15, 11, 8, 20, and 44%, respectively. The corresponding HbA1c values on follow-up were 5, 30, 14, 11, 17, and 23%, respectively. Sodium-glucose transport protein 2 inhibitor (SGLT2i) group was in poorer control (HbA1c 8.20 ± 1.71) at follow-up than non-SGLT2i group (HbA1c 7.55 ± 1.72), p < 0.001) probably due to significantly greater use of sulphonylurea as background therapy in SGLT2i group (SGLT2i group 72.2%, non-SGLT2i group 58.7%, p < 0.02). Initial ABC targets were at goal for HbA1c, high blood pressure, and low-density lipoprotein (LDL) cholesterol in 17, 40, and 33% of patients, respectively. On follow-up, percent of patients at goal were HbA1c 35%, hypertension 95.77%, and LDL cholesterol 75.85%.
Conclusion: The study brings out the difficulties in achieving HbA1c goals as compared to blood pressure and LDL cholesterol goals. Additionally, it brings out the efficacy of sulphonylureas as a treatment mo dality Longer duration of diabetes resulted in lower achievement of glycemic targets ©The Author(s).
Authors : Chandalia H.B.; Jain J.D.; Chandalia S.H.
Source : Journal of Association of Physicians of India
Article Information
| Year | 2024 |
| Type | Article |
| DOI | 10.59556/japi.72.0730 |
| ISSN | 00045772 |
| Volume | 72 |
You can download the article here
If You have any problem, contact us here